News.abbvie.com

U.S. FDA Approves VRAYLAR® (cariprazine) as an Adjunctive …

WEB- Approval marks fourth indication for VRAYLAR, backed by proven efficacy and well-established tolerability as an adjunctive treatment for major depressive disorder …

Actived: Just Now

URL: https://news.abbvie.com/2022-12-16-U-S-FDA-Approves-VRAYLAR-R-cariprazine-as-an-Adjunctive-Treatment-for-Major-Depressive-Disorder

AbbVie Announces Partners in $50 Million Program to Promote …

WEBNORTH CHICAGO, Ill., Dec. 9, 2020 /PRNewswire/ -- AbbVie, a research-based global biopharmaceutical company, is investing $50 million in a five-year program to support …

Category: Health Go Health

U.S. FDA Approves RINVOQ® (upadacitinib) as a Once-Daily Pill …

WEB– The co-primary endpoints of endoscopic response (visible reduction of intestinal lining damage) and clinical remission were achieved by significantly more …

Category: Health Go Health

AbbVie to Acquire ImmunoGen, including its Flagship Cancer …

WEBProposed acquisition will accelerate AbbVie's entry into the commercial market for ovarian cancer; ELAHERE ® is a first-in-class antibody-drug conjugate (ADC) …

Category: Cancer Go Health

VUITY™ (pilocarpine HCI ophthalmic solution) 1.25%, the First and …

WEBNORTH CHICAGO, Ill., Dec. 9, 2021 /PRNewswire/ -- Allergan, an AbbVie (NYSE: ABBV) company, today announced that VUITY ™ (pilocarpine HCl ophthalmic solution) 1.25%, …

Category: Health Go Health

AbbVie News Center

WEBAbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease Week®. May 13, 2024.

Category: Health Go Health

AbbVie News Center

WEBThe digital health revolution has led to a massive increase in the amount of data available, opening new frontiers in science and medicine. AbbVie is leading one of …

Category: Medicine Go Health

AbbVie and Umoja Biopharma Announce Strategic Collaboration …

WEBCollaboration to leverage Umoja's VivoVec TM gene delivery platform and AbbVie's expertise in oncology to develop in-situ generated chimeric antigen receptor …

Category: Health Go Health

AbbVie to Acquire Cerevel Therapeutics in Transformative …

WEBNotice. The "Yes" link below will take you out of the AbbVie family of websites. Links which take you out of the AbbVie worldwide websites are not under the …

Category: Health Go Health

AbbVie Announces Positive Topline Results from Phase 2 …

WEBLUMINOSITY trial demonstrated compelling clinical benefits across key endpoints; Teliso-V is an investigational first-in-class, c-Met protein directed antibody …

Category: Health Go Health

AbbVie and Tentarix Announce Collaboration to Develop …

WEBCollaboration to leverage AbbVie's therapeutic area expertise and Tentarix's Tentacles™ platform, to develop novel multifunctional biologics against one target in …

Category: Health Go Health

AbbVie Completes Transformative Acquisition of Allergan

WEBMr. Freyman recently served on the Allergan Board of Directors. Under the terms of the transaction agreement, Allergan shareholders will receive 0.8660 AbbVie …

Category: Health Go Health

AbbVie and Calico Announce Second Extension of Collaboration …

WEBNORTH CHICAGO, Ill. and SOUTH SAN FRANCISCO, Calif., July 27, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) and Calico Life Sciences today announced an …

Category: Health Go Health

AbbVie Exercises Exclusive Right to Acquire Mitokinin, Further

WEBFor further information: Contact(s): Media: Jane Woo, (224) 864-3846, [email protected] or Investors: Liz Shea, (847) 935-2211, [email protected]

Category: Health Go Health

Natrelle® Unveils New "For Every BODY" Campaign

WEBIRVINE, Calif., Nov. 8, 2023 / PRNewswire / -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), embraces the immensely personal choice that patients experience when …

Category: Health Go Health

AbbVie Highlights Blood Cancer Data From Its Growing Oncology …

WEBThe ASH 2022 Annual Meeting abstracts are available here.. Epcoritamab is an investigational anti-CD20 x CD3 bispecific antibody being co-developed by AbbVie …

Category: Health Go Health

AbbVie and BigHat Biosciences Announce Research Collaboration …

WEBCollaboration to leverage BigHat's Artificial Intelligence and Machine Learning (AI/ML) guided Milliner™ platform and AbbVie's expertise in Oncology and …

Category: Health Go Health

AbbVie to Present at the 42nd Annual J.P. Morgan Healthcare …

WEBNORTH CHICAGO, Ill., Jan. 2, 2024 / PRNewswire / -- AbbVie (NYSE: ABBV) will participate in the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, …

Category: Health Go Health

AbbVie Expands Biologics Manufacturing Capacity with a $223 …

WEB– US$223 million expansion will add biologics capacity to AbbVie manufacturing network – Singapore manufacturing site to grow to more than 500 …

Category: Health Go Health

Top Categories

› Appendicitis

› Gout

› Women's Health

› Thyroid

› Sleep

› Skin

› Sexual Health

› Senior Health

› Oral Health

› Mental Health

› Men's Health

› Medications

› Lung Conditions

› Infectious Disease

Popular Searched

› Best practices for healthcare engineering

› New mexico health care laws 2022

› Healthy baked crab cakes recipe

› Research on health insurance in india

› Health shield insurance quotes

› Mental health co operative tn

› American health associates medlab

› Teamwork in a healthcare setting

› School nurse mental health issues

› Boy scout health form c

Recently Searched

› United health care individual trip plan

› Best nuts for health

› The healthy bug halifax ns

› Axa framlington health share price

› Crider health center dental insider

› St clair health pricing

› Allied health transition to practice

› Island public health department

› Health for life lancaster pa

› Project based health lessons

The medical information found on the MediWells website is designed to support, not to replace the relationship between patient and physician and the medical advice they may provide.